QP 30 - Head and Neck QP:

Presentations

• 05:00pm - 05:05pm ET

  Introductions

  Speaker: Anthony Apicelli, MD, PhD - Washington University, St. Louis
• 05:05pm - 05:10pm ET

  Radiotherapy Dose De-Escalation in HPV-Associated Cancers of the Oropharynx Using Metabolic Signature from Interim 18FDG-PET/CT

  Speaker: Jared Robbins, MD - Duke University School of Medicine, Durham
• 05:10pm - 05:15pm ET

  Practice Variation In IMPT Treatment Planning in Oropharyngeal Cancer: Dose Differences and Expected Impact on Toxicity Outcome

  Speaker: Johannes Langendijk, MD, PhD - University Medical Center Groningen, Groningen
• 05:15pm - 05:20pm ET

  Patient Reported Symptom Trajectories during and after Radiotherapy (RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC): A TROG 12.01 Secondary Analysis

  Speaker: Justin Smith, MBBS - Princess Alexandra Hospital, Woolloongabba
• 05:20pm - 05:25pm ET

  Locoregional Control and Dosimetry after Standard-Dose vs. Reduced-Dose Elective Nodal Chemoradiotherapy for HPV-Associated Oropharyngeal Carcinoma

  Speaker: Michael Bian, BS - Case Western Reserve University, Cleveland
• 05:25pm - 05:30pm ET

  Elective Nodal Irradiation to 44 Gy with Sequential IMRT Boost in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

  Speaker: Michael Chisam, MD - Duke University, Durham
• 05:30pm - 05:35pm ET

  The Impact of Imaging-Detected Extranodal Extension on Treatment De-Escalation for HPV-Related Oropharyngeal Cancer: A Pooled Analysis of Prospectively Treated Patients

  Speaker: Montserrat Quintana, MD - University of Chicago, Chicago
• 05:35pm - 05:55pm ET

  Questions & Answers

  Speaker: Yao Yu, MD - Memorial Sloan Kettering Cancer Center, New York
• 05:55pm - 06:00pm ET

  Closing

  Speaker: Anthony Apicelli, MD, PhD - Washington University, St. Louis